Previous close | 23.44 |
Open | 23.30 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 23.44 - 23.44 |
52-week range | 11.62 - 23.44 |
Volume | |
Avg. volume | 3 |
Market cap | 1.407B |
Beta (5Y monthly) | 0.80 |
PE ratio (TTM) | 1.53 |
EPS (TTM) | 15.29 |
Earnings date | N/A |
Forward dividend & yield | 1.58 (6.74%) |
Ex-dividend date | 02 May 2022 |
1y target est | N/A |
EQS-News: Semperit AG Holding / Key word(s): Quarterly / Interim Statement/Quarter ResultsSemperit AG Holding delivers a strong performance in the first quarter but is behind the exceptionally high results from the corresponding period as expected 18.05.2022 / 07:30 The issuer is solely responsible for the content of this announcement. Semperit delivers a strong performance in the first quarter but is behind the exceptionally high results from the corresponding period as expected Revenue at Grou
EQS-News: Semperit AG Holding / Key word(s): AGM/EGM/DividendSemperit AG Holding: Annual General Meeting approves dividend of EUR 1.50 per share for 2021 27.04.2022 / 15:28 The issuer is solely responsible for the content of this announcement.Vienna/Austria, 27 April, 2022 - At the 133rd Annual General Meeting of Semperit AG Holding, the Executive Board's proposal to pay a dividend of EUR 1.50 per share to shareholders for 2021 was approved.Herbert Ortner was re-elected as a member of the Superv
EQS-News: Semperit AG Holding / Key word(s): Annual Results23.03.2022 / 07:30 The issuer is solely responsible for the content of this announcement.Press releaseSemperit posts record result again in 2021 despite difficult conditions - revenue exceed billion-euro threshold- Consolidated sales increased by 27.4% to EUR 1,182.2 million in 2021- Revenue in the Industrial Sector grew by 16.2% to EUR 556.1 million and by 39.4% to EUR 626.1 million in the Medical Sector- EBITDA increased by 73.5% to EU